N/A
N=192
Aides in Respiration Health Coaching for COPD
Chronic Obstructive Pulmonary Disease (COPD)
Bottom Line
View on ClinicalTrials.gov: NCT02234284 ↗Enrolled (actual)
192
Serious AEs
25.0%
Results posted
Jun 2019
Primary outcome: Primary: Short Form Chronic Respiratory Disease Questionnaire (CRQ-SF) Total Score — 4.58; 4.43 units on a scale — p=.35
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Health Coaching (Behavioral)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- University of California, San Francisco
- Primary completion
- May 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Short Form Chronic Respiratory Disease Questionnaire (CRQ-SF) Total Score |
4.58; 4.43 | .35 |
| PRIMARY Dyspnea Domain Score of the Short Form of the Chronic Respiratory Disease Questionnaire (CRQ-SF) |
4.98; 4.78 | .20 |
| SECONDARY Rate of COPD Exacerbations Per Year |
1.17; 1.44 | .13 |
| SECONDARY Exercise Capacity (6-minute Walk Test) |
326; 311 | .32 |
| SECONDARY Self-efficacy to Manage Chronic Disease Scale |
6.84; 6.50 | .27 |
Summary
This study examined whether health coaches can improve the management of chronic obstructive pulmonary disease (COPD) in a population of vulnerable patients cared for in 'safety-net' clinics. The study is designed as a randomized controlled trial for patients with moderate to severe COPD. Patients were randomized into a health coaching group and a usual care group. Those in the health coaching group received 9 months of active health coaching. Outcome variables were measured at baseline and after 9 months
Eligibility Criteria
Inclusion Criteria
- Patient at one of the participating primary care clinics (at least 1 visit in past 12 months)
- Age 40 and older
- Speaking English or Spanish
- Plan to continue to be seen at current clinic and to not leave the area for >2 months anytime in the next 9 months or to be absent at 9 or 15 months
- COPD defined as ever having had a post-bronchodilator Forced Expiratory Volume in 1 second/Forced Vital Capacity (FEV1/FVC) /=10 OR an modified Medical Research Council (mMRC) score of >/=2).
- Currently using tiotropium inhaler or combination inhaled corticosteroid and long-acting beta agonist
Exclusion Criteria
- Unable to participate in the study due to mental or physical impairment
- Severe or terminal illness that precludes focus on COPD
- No phone
Data sourced from ClinicalTrials.gov (NCT02234284). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.